Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jun;33(6):923-931.
doi: 10.1101/gr.277585.122. Epub 2023 May 11.

Efficient and accurate KIR and HLA genotyping with massively parallel sequencing data

Affiliations

Efficient and accurate KIR and HLA genotyping with massively parallel sequencing data

Li Song et al. Genome Res. 2023 Jun.

Abstract

Killer cell immunoglobulin like receptor (KIR) genes and human leukocyte antigen (HLA) genes play important roles in innate and adaptive immunity. They are highly polymorphic and cannot be genotyped with standard variant calling pipelines. Compared with HLA genes, many KIR genes are similar to each other in sequences and may be absent in the chromosomes. Therefore, although many tools have been developed to genotype HLA genes using common sequencing data, none of them work for KIR genes. Even specialized KIR genotypers could not resolve all the KIR genes. Here we describe T1K, a novel computational method for the efficient and accurate inference of KIR or HLA alleles from RNA-seq, whole-genome sequencing, or whole-exome sequencing data. T1K jointly considers alleles across all genotyped genes, so it can reliably identify present genes and distinguish homologous genes, including the challenging KIR2DL5A/KIR2DL5B genes. This model also benefits HLA genotyping, where T1K achieves high accuracy in benchmarks. Moreover, T1K can call novel single-nucleotide variants and process single-cell data. Applying T1K to tumor single-cell RNA-seq data, we found that KIR2DL4 expression was enriched in tumor-specific CD8+ T cells. T1K may open the opportunity for HLA and KIR genotyping across various sequencing applications.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Evaluation of T1K. (A) Overview of the T1K workflow. (B) The KIR allele prediction accuracy of T1K and T1K with no multiple-gene mapped reads (mimicking arcasHLA) on simulated reads from KIR mRNAs. (FN) False negative; (FP) false positive. (C) The KIR allele prediction accuracy of T1K on WGS. (HPRC matched) The alleles inferred from the HPRC phased genome that can be found in T1K predictions; (T1K matched) the alleles predicted by T1K that can be found on HPRC genomes. (D) The HLA allele prediction accuracy of T1K, arcasHLA, and OptiType on RNA-seq data validated with 1kPG annotation. (E) The HLA allele prediction accuracy of T1K and OptiType on WES data validated with 1kPG annotation. With T1K_whitelist, T1K only reports alleles present in an allele whitelist coded in OptiType's Python script.
Figure 2.
Figure 2.
KIR alleles in CD8+ T cells. (A) KIR allele expression fractions in four cells from a colorectal cancer (CRC) patient. (B) The number of expressed KIR alleles in a cell. For example, seven cells expressed two KIR alleles. (C) The number of cells that express the KIR gene, splitting by the cases of single-allele expression or both-allele expression. Only detected KIR genes are displayed. (D) Comparison of the KIR allele fractions between CD39 CD8+ T cells and CD39+ CD8+ T cells. Each line connects a KIR allele in the CD39 cell and the CD39+ T cell from the same patient. The P-values are computed with a Wilcoxon signed-rank test and have been adjusted by the Benjamini–Hochberg procedure.

Similar articles

Cited by

References

    1. The 1000 Genomes Project Consortium. 2012. An integrated map of genetic variation from 1,092 human genomes. Nature 491: 56–65. 10.1038/nature11632 - DOI - PMC - PubMed
    1. Abi-Rached L, Gouret P, Yeh J-H, Di Cristofaro J, Pontarotti P, Picard C, Paganini J. 2018. Immune diversity sheds light on missing variation in worldwide genetic diversity panels. PLoS One 13: e0206512. 10.1371/journal.pone.0206512 - DOI - PMC - PubMed
    1. Bhatt RS, Berjis A, Konge JC, Mahoney KM, Klee AN, Freeman SS, Chen C-H, Jegede OA, Catalano PJ, Pignon J-C, et al. 2021. KIR3DL3 is an inhibitory receptor for HHLA2 that mediates an alternative immunoinhibitory pathway to PD1. Cancer Immunol Res 9: 156–169. 10.1158/2326-6066.CIR-20-0315 - DOI - PMC - PubMed
    1. Björkström NK, Béziat V, Cichocki F, Liu LL, Levine J, Larsson S, Koup RA, Anderson SK, Ljunggren H-G, Malmberg K-J. 2012. CD8 T cells express randomly selected KIRs with distinct specificities compared with NK cells. Blood 120: 3455–3465. 10.1182/blood-2012-03-416867 - DOI - PMC - PubMed
    1. Boegel S, Löwer M, Schäfer M, Bukur T, de Graaf J, Boisguérin V, Türeci O, Diken M, Castle JC, Sahin U. 2012. HLA typing from RNA-Seq sequence reads. Genome Med 4: 102. 10.1186/gm403 - DOI - PMC - PubMed

Publication types